Glenmark Pharmaceuticals shares are currently trading at ₹1,553.60, marking an increase of 0.92% as the company gears up to release its second-quarter earnings.
With a total market cap of ₹43,840.75 crore, the stock has a 52-week high of ₹1,830.95 and a low of ₹730.05. Investors are closely monitoring Glenmark’s performance as it prepares to report its financial results.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
Ahmedabad Plane Crash